Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.W | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by enriquesuaveon Mar 27, 2024 11:55pm
179 Views
Post# 35957172

RE:RE:Plan to resubmit early Q1 to FDA

RE:RE:Plan to resubmit early Q1 to FDA

From what I understand, once pre BTD is submitted, they will know within days if all is OK to submit full BTD.  Then BTD takes 60 days, so if they end up submitting pre BTD early Q2 hopefully, then it's possible to get BTD submitted also early Q2 and get answer end of Q2 or early Q3 ( June -July).  All IMHO and a good question to ask.


judgesmails wrote: Agreed.  Plan from before Christmas was pre BDT submission in early Q1 and actual BTD later in Q1.

Then January update said pre BTD in Q1 sometime and BTD in Q2.

Now it is pre BTD in Q2 and BTD submission later. Hopefully later in Q2...but not necessarily.

"The Company plans to resubmit the pre-BTD submission to the FDA in 2Q2024 for FDA review of these clarifications. Once the pre-BTD submission has been accepted by the FDA, the Company will compile a BTD submission for review by the FDA in support of the grant of a BTD approval."
.
It would be nice to understand something about the delays

 

<< Previous
Bullboard Posts
Next >>